Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded
- Contract number
- SPE2DB25FQJNT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,615
Award facts
- Contract value 100% obligated
- $41,615.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,615.46 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pen injections. The contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated substantial capability in fulfilling competitive federal healthcare supply requirements across multiple therapeutic domains. The company's extensive portfolio with DLA includes diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This delivery order for Teriparatide, a bone-building medication commonly used to treat osteoporosis, reflects the company's role as a primary supplier supporting the Defense Health Agency and other federal healthcare systems through open competition and firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DB25FQJNT?
SPE2DB25FQJNT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FQJNT worth?
The government has obligated $41,615 on SPE2DB25FQJNT.
Is contract SPE2DB25FQJNT an order under another contract?
Yes. SPE2DB25FQJNT is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJNT competed?
The extent of competition for SPE2DB25FQJNT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award